Cardiol Therapeutics Inc., (TSX: CRDL) (OTCQX: CRTPF) is focused on producing pharmaceutical cannabi...
President and CEO
David Elsley, president and CEO of Cardiol Therapeutics, has more than 25 years of experience developing, financing, and managing all aspects of corporate development of biotechnology and high-growth organizations. He is also the founder and former president and CEO of Vasogen, Inc.
Content from David Elsley
David Elsley, president and CEO, provides a corporate presentation on how Cardiol Therapeutics (TSX:...